The putative alpha-1,2-mannosyltransferase AfMnt1 of the opportunistic fungal pathogen Aspergillus fumigatus is required for cell wall stability and full virulence.

Eukaryotic Cell
Johannes WagenerFrank Ebel

Abstract

Proteins entering the eukaryotic secretory pathway commonly are glycosylated. Important steps in this posttranslational modification are carried out by mannosyltransferases. In this study, we investigated the putative alpha-1,2-mannosyltransferase AfMnt1 of the human pathogenic mold Aspergillus fumigatus. AfMnt1 belongs to a family of enzymes that comprises nine members in Saccharomyces cerevisiae but only three in A. fumigatus. A Deltaafmnt1 mutant is viable and grows normally at 37 degrees C, but its hyphal cell wall appears to be thinner than that of the parental strain. The lack of AfMnt1 leads to a higher sensitivity to calcofluor white and Congo red but not to sodium dodecyl sulfate. The growth of the mutant is abrogated at 48 degrees C but can be restored by osmotic stabilization. The resulting colonies remain white due to a defect in the formation of conidia. Electron and immunofluorescence microscopy further revealed that the observed growth defect of the mutant at 48 degrees C can be attributed to cell wall instability resulting in leakage at the hyphal tips. Using a red fluorescence fusion protein, we localized AfMnt1 in compact, brefeldin A-sensitive organelles that most likely represent fungal Golgi equivalents. Th...Continue Reading

References

Apr 1, 1978·Chemico-biological Interactions·H van den BosscheL Le Jeune
Jan 1, 1992·Methods in Enzymology·P J Punt, C A van den Hondel
Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·A HäuslerP W Robbins
Jan 1, 1969·Journal of Ultrastructure Research·A R Spurr
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·E T BuurmanN A Gow
Jan 8, 1999·Biochimica Et Biophysica Acta·M LussierH Bussey
Apr 9, 1999·Clinical Microbiology Reviews·J P Latgé
Aug 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M M McNeilD W Warnock
Jun 8, 2004·Current Drug Targets. Infectious Disorders·Daniel GozalboMaría Luisa Gil
Jul 1, 2004·Bioorganic & Medicinal Chemistry Letters·Michael G OrchardMartin Page
Aug 24, 2006·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Shaun M Bowman, Stephen J Free
Oct 27, 2006·Current Infectious Disease Reports·Arlo Upton, Kieren A Marr
Sep 15, 2007·Molecular Microbiology·Jean-Paul Latgé
Nov 8, 2007·FEMS Microbiology Letters·Andrew BreakspearSusan J Assinder

❮ Previous
Next ❯

Citations

Oct 21, 2009·The Journal of Biological Chemistry·Jakob EngelFrançoise H Routier
Jan 29, 2011·BMC Genomics·Ana Karina R AbadioMaria Sueli S Felipe
Apr 20, 2014·Fungal Biology·Ekaterina MinenkoLudwig Niessen
Sep 29, 2011·Chembiochem : a European Journal of Chemical Biology·Andrea MaggioniJoe Tiralongo
Aug 29, 2013·BioMed Research International·Helioswilton Sales-CamposMárcia Regina Von Zeska Kress
Sep 8, 2016·Cellular Microbiology·Christine HenryJean-Paul Latgé
Dec 13, 2016·International Journal of Medical Microbiology : IJMM·Bernadette GeißelJohannes Wagener
Dec 1, 2018·PLoS Genetics·Elizabeth Medina-CastellanosAlfredo Herrera-Estrella
Sep 7, 2019·Current Protein & Peptide Science·Verónica PlazaLuis Castillo
Jan 1, 2020·Current Protein & Peptide Science·Laura C García-CarneroAlma K Tamez-Castrellón
Aug 19, 2010·Cellular Microbiology·Allison McCormickFrank Ebel
Jan 16, 2018·Bioscience, Biotechnology, and Biochemistry·Takuji Oka
Oct 15, 2019·Frontiers in Microbiology·Maíra P MartinsNilce M Martinez-Rossi
Sep 19, 2020·Medical Mycology·Margherita BertuzziElaine M Bignell
Jun 1, 2017·Frontiers in Microbiology·Guillaume Desoubeaux, Carolyn Cray
Jun 6, 2018·Frontiers in Cellular and Infection Microbiology·Dominik RufJohannes Wagener
Aug 8, 2018·Nature Communications·Bernadette GeißelJohannes Wagener
Apr 23, 2020·Frontiers in Microbiology·Ralph GötzUlrich Terpitz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.